| Literature DB >> 26683902 |
Luqia Hou1, Joseph J Kim1, Y Joseph Woo2, Ngan F Huang3.
Abstract
Stem cell therapy is a promising approach for the treatment of tissue ischemia associated with myocardial infarction and peripheral arterial disease. Stem and progenitor cells derived from bone marrow or from pluripotent stem cells have shown therapeutic benefit in boosting angiogenesis as well as restoring tissue function. Notably, adult stem and progenitor cells including mononuclear cells, endothelial progenitor cells, and mesenchymal stem cells have progressed into clinical trials and have shown positive benefits. In this review, we overview the major classes of stem and progenitor cells, including pluripotent stem cells, and summarize the state of the art in applying these cell types for treating myocardial infarction and peripheral arterial disease.Entities:
Keywords: angiogenesis; hindlimb ischemia; myocardial infarction; peripheral arterial disease; pluripotent stem cell; stem cell therapy
Mesh:
Year: 2015 PMID: 26683902 PMCID: PMC4796616 DOI: 10.1152/ajpheart.00726.2015
Source DB: PubMed Journal: Am J Physiol Heart Circ Physiol ISSN: 0363-6135 Impact factor: 4.733